Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease (Q33628389)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease |
scientific article |
Statements
1 reference
Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease (English)
1 reference
Todd R Golub
1 reference
Job Dekker
1 reference
Stuart L Schreiber
1 reference
James E Bradner
1 reference
Raymond Mak
1 reference
Shyam K Tanguturi
1 reference
Ralph Mazitschek
1 reference
Stephen J Haggarty
1 reference
Kenneth Ross
1 reference
Cindy Y Chang
1 reference
Jocelyn Bosco
1 reference
Nathan West
1 reference
Elizabeth Morse
1 reference
Katherine Lin
1 reference
John Paul Shen
1 reference
Nicholas P Kwiatkowski
1 reference
Nele Gheldof
1 reference
Daniel J DeAngelo
1 reference
Steven A Carr
1 reference
Benjamin L Ebert
1 reference
28 June 2010
1 reference
107
1 reference
28
1 reference
12617-12622
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference